{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:15:24Z","timestamp":1764656124103,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.diagmicrobio.2021.115314","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:25:02Z","timestamp":1611267902000},"page":"115314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012\u201320017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance"],"prefix":"10.1016","volume":"100","author":[{"given":"Brian D.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Thuras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Clabots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Johnsona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0001","article-title":"Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131","volume":"7","author":"Ben Zakour","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0002","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/jac\/dkx146","article-title":"Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype","volume":"72","author":"Bevan","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0003","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3201\/eid2305.161865","article-title":"CTX-M-27\u2013producing Escherichia coli of sequence type 131 and clade C1-M27, France","volume":"23","author":"Birgy","year":"2017","journal-title":"Emerg Inf Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0004","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.2832","article-title":"Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations","volume":"26","author":"Campbell","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M beta-lactamase pandemic","volume":"9","author":"Canton","year":"2006","journal-title":"Curr Opin Microbiol"},{"year":"2019","series-title":"Antibiotic resistance threats in the United States, 2019","key":"10.1016\/j.diagmicrobio.2021.115314_bib0006"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0007","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mimet.2014.03.008","article-title":"Development of an allele-specific PCR for Escherichia coli B2 sub-typing, a rapid and easy to perform substitute of multilocus sequence typing","volume":"101","author":"Clermont","year":"2014","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1758-2229.12019","article-title":"The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups","volume":"5","author":"Clermont","year":"2012","journal-title":"Environ Microbiol Rep"},{"journal-title":"M100: Performance standards for antimicrobial susceptibility testing","year":"2020","key":"10.1016\/j.diagmicrobio.2021.115314_bib0010"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0011","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Maladies Infect"},{"issue":"suppl 3","key":"10.1016\/j.diagmicrobio.2021.115314_bib0012","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/jac\/dky027","article-title":"Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy\/Healthcare Infection Society\/British Infection Association Joint Working Party","volume":"73","author":"Hawkey","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0013","doi-asserted-by":"crossref","first-page":"ofx089","DOI":"10.1093\/ofid\/ofx089","article-title":"The pandemic H30 subclone of sequence type 131 (ST131) is the leading cause of multidrug-resistant Escherichia coli infections in the United States (2011-2012)","volume":"4","author":"Johnson","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0014","doi-asserted-by":"crossref","first-page":"ofw129","DOI":"10.1093\/ofid\/ofw129","article-title":"Household clustering of Escherichia coli sequence type 131 clinical and fecal isolates according to whole genome sequence analysis","volume":"3","author":"Johnson","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0015","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00673-15","article-title":"Intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 vs. other fluoroquinolone-resistant E. coli","volume":"59","author":"Johnson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01664-18","article-title":"Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64 (ST1193-H64), a new disseminated multidrug-resistant commensal and extraintestinal pathogen","volume":"57","author":"Johnson","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00732-17","article-title":"Epidemic emergence in the United States of Escherichia coli sequence type 131-H30 (ST131-H30), 2000-2009","volume":"61","author":"Johnson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0018","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1128\/AAC.01687-15","article-title":"Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131","volume":"59","author":"Johnson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0019","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jis933","article-title":"Abrupt emergence of a single dominant multi-drug-resistant strain of Escherichia coli","volume":"207","author":"Johnson","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0020","article-title":"Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against carbapenem-resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, coresistance, and region","volume":"64","author":"Johnston","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0021","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/AAC.00912-17","article-title":"Genomic analysis of multidrug-resistant Escherichia coli from North Carolina community hospitals: ongoing circulation of CTX-M-producing ST131-H30Rx and ST131-H30R1 strains","volume":"61","author":"Kanamori","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diagmicrobio.2015.10.016","article-title":"Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea","volume":"84","author":"Kim","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0023","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/pharmaceutics10020066","article-title":"Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis","volume":"10","author":"Luaces-Rodr\u00edguez","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jac\/dkv017","article-title":"CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic","volume":"70","author":"Matsumura","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0026","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid2211.160519","article-title":"Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene","volume":"22","author":"Matsumura","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006280","article-title":"Combined analysis of variation in core, accessory and regulatory genome regions provides a super-resolution view into the evolution of bacterial populations","volume":"12","author":"McNally","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0028","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system Infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkm464","article-title":"Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15","volume":"61","author":"Nicolas-Chanoine","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0031","article-title":"The epidemic of ESBL-producing Escherichia coli ST131 is driven by a single highly virulent subclone, H30-Rx","volume":"6","author":"Price","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0032","first-page":"161","article-title":"Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals","volume":"209","author":"Saladin","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02162-15","article-title":"Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131","volume":"7","author":"Stoesser","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0034","doi-asserted-by":"crossref","first-page":"fw002","DOI":"10.1093\/ofid\/ofw002","article-title":"A novel 7-single nucleotide polymorphism-based clonotyping test allows rapid prediction of antimicrobial susceptibility of extraintestinal Escherichia coli directly from urine specimens","volume":"3","author":"Tchesnokova","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115314_bib0035","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/JCM.00984-13","article-title":"Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome","volume":"51","author":"Tchesnokova","year":"2013","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:55:40Z","timestamp":1760003740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0732889321000079"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115314","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012\u201320017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115314"}}